lobbying_activities: 1807311

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1807311	16d4a9e2-91fd-48d3-9733-ab52eeb11cdf	Q1	MASSACHUSETTS MEDICAL SOCIETY	23975	MASSACHUSETTS MEDICAL SOCIETY	2016	first_quarter	PHA	S 320 - Medical Innovation Act - NIH funding DEA - change/classification of regulations regarding partial fill of prescriptions Prescription Drug Pricing - no specific bill Direct to Consumer Advertising - no specific bill Negotiating Prescription Drug Prices for Medicare and Medicaid - no specific bill	Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS)		90000	0	0	2016-04-14T11:16:15.737000-04:00